GE HealthCare (GEHC) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/29/26
GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growthBusiness Wire • 04/29/26
GEHC Moves Manganese-Based MRI Contrast Agent Into Phase 2/3 TrialZacks Investment Research • 04/24/26
GE HealthCare to Post Q1 Earnings: What's in Store for the Stock?Zacks Investment Research • 04/23/26
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging AgentsBusiness Wire • 04/23/26
Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to WatchZacks Investment Research • 04/20/26
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutionsBusiness Wire • 04/16/26
GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery ImagingZacks Investment Research • 04/10/26
The GE Family Divided: Comparing Valuations, Growth Rates, and Analyst Sentiment Across 3 Sectors24/7 Wall Street • 04/09/26
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-TermZacks Investment Research • 04/09/26
GE HealthCare announces digital integration between bkActiv™ intraoperative ultrasound system and Medtronic Stealth AXiS™ surgical navigation systemBusiness Wire • 04/09/26
GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin LimitedBusiness Wire • 03/31/26
All You Need to Know About GE HealthCare (GEHC) Rating Upgrade to BuyZacks Investment Research • 03/27/26
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across EuropeBusiness Wire • 03/26/26